Education
About Us
Working with TipRanks
Follow Us
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Total Valuation
Fusen Pharmaceutical Co., Ltd. has a market cap or net worth of HK$187.48M. The enterprise value is HK$1.01B.
Market CapHK$187.48M
Enterprise ValueHK$1.01B
Share Statistics
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding739,301,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fusen Pharmaceutical Co., Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee500.10K
Profits Per Employee-26.04K
Employee Count1,131
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Fusen Pharmaceutical Co., Ltd. is ―. Fusen Pharmaceutical Co., Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Fusen Pharmaceutical Co., Ltd. had revenue of 565.61M and earned -36.28M in profits. Earnings per share was -0.05.
Revenue565.61M
Gross Profit299.51M
Operating Income20.02M
Pretax Income-29.45M
Net Income-36.28M
EBITDA18.93M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -33.25M and capital expenditures -70.20M, giving a free cash flow of -103.44M billion.
Operating Cash Flow-33.25M
Free Cash Flow-103.44M
Free Cash Flow per Share-0.14
Dividends & Yields
Fusen Pharmaceutical Co., Ltd. pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.12
52-Week Price Change-70.00%
50-Day Moving Average0.29
200-Day Moving Average0.76
Relative Strength Index (RSI)41.70
Average Volume (3m)161.50K
Important Dates
Fusen Pharmaceutical Co., Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 07, 2022
Financial Position
Fusen Pharmaceutical Co., Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Fusen Pharmaceutical Co., Ltd. has paid 6.85M in taxes.
Income Tax6.85M
Effective Tax Rate―
Enterprise Valuation
Fusen Pharmaceutical Co., Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Fusen Pharmaceutical Co., Ltd. has HK$2.82M in cash and marketable securities with ¥190.00M in debt, giving a net cash position of HK$347.81M billion.
Cash & Marketable SecuritiesHK$2.82M
Total Debt¥190.00M
Net CashHK$347.81M
Net Cash Per ShareHK$0.47
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Fusen Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-43.73%
EPS Growth Forecast-434.17%